Tag: returning-its
-
Merck patents on Hepatitis C treatment found valid in Gilead dispute
By Rory Carroll and Andrew Chung SAN JOSE (Reuters) – Merck & Co told a federal jury on Tuesday it was seeking more than $2 billion in damages from rival Gilead Sciences Inc after the jury upheld the validity of two Merck patents in a high-profile dispute over Gilead's blockbuster cure for hepatitis C. After…
-
Syrian refugees denied critical healthcare in Jordan: Amnesty
Syrian refugees in Jordan are finding it very difficult to get medical care because of Jordanian fees and bureaucracy, and shrinking humanitarian financial support, rights group Amnesty International said on Wednesday. Many refugees cannot afford the fees for medical care imposed by the Jordanian government in 2014, and some, injured in the Syrian conflict, have…